147 related articles for article (PubMed ID: 10390751)
1. [Akathisia, parkinsonism and depression induced by cinnarizine: a case report].
Stucchi-Portocarrero S; Vega-Dienstmaier JM; Saavedra JE; Sagástegui A
Rev Neurol; 1999 May 1-15; 28(9):876-8. PubMed ID: 10390751
[TBL] [Abstract][Full Text] [Related]
2. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
Jung HY; Kim JH; Ahn YM; Kim SC; Hwang SS; Kim YS
Hum Psychopharmacol; 2005 Jan; 20(1):41-5. PubMed ID: 15565639
[TBL] [Abstract][Full Text] [Related]
3. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
4. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.
Chouza C; Scaramelli A; Caamaño JL; De Medina O; Aljanati R; Romero S
Lancet; 1986 Jun; 1(8493):1303-4. PubMed ID: 2872433
[TBL] [Abstract][Full Text] [Related]
5. Movement disorders and depression due to flunarizine and cinnarizine.
Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
[TBL] [Abstract][Full Text] [Related]
6. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
[TBL] [Abstract][Full Text] [Related]
7. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
9. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute neuroleptic-induced movement disorders.
Tonda ME; Guthrie SK
Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
[TBL] [Abstract][Full Text] [Related]
11. Tardive blepharospasm associated with cinnarizine use.
Alonso-Navarro H; Jiménez-Jiménez FJ
Clin Neuropharmacol; 2006; 29(4):187-9. PubMed ID: 16855418
[TBL] [Abstract][Full Text] [Related]
12. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
Teive HA; Troiano AR; Germiniani FM; Werneck LC
Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
[TBL] [Abstract][Full Text] [Related]
13. [Parkinsonism due to the medication].
Louter M; Tromp SC
Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
[TBL] [Abstract][Full Text] [Related]
14. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
Negrotti A; Calzetti S; Sasso E
Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
[TBL] [Abstract][Full Text] [Related]
15. Extrapyramidal symptoms associated with calcium-channel blockers.
Daniel JR; Mauro VF
Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350
[TBL] [Abstract][Full Text] [Related]
16. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
[TBL] [Abstract][Full Text] [Related]
17. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
18. Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases.
Masmoudi K; Masson H; Gras V; Andréjak M
Fundam Clin Pharmacol; 2012 Apr; 26(2):198-203. PubMed ID: 22044594
[TBL] [Abstract][Full Text] [Related]
19. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.
Hansen L; Jones RM; Kingdon D
J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982
[TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal syndromes caused by antipsychotics.
Jesić MP; Jesić A; Filipović JB; Zivanović O
Med Pregl; 2012; 65(11-12):521-6. PubMed ID: 23297621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
